Search

everythinglearnresearchcommunity

for

Search:↓

CGRP MAbs treatment for migraines may also improve rosacea symptoms, but more research is needed to confirm its effectiveness and safety.

RXR agonists may promote hair growth in humans.

Mutations in the glucocorticoid receptor gene cause reduced sensitivity to glucocorticoids and may lead to poor response to treatment.

ASLNC168501 may help restore hair growth in androgenetic alopecia by improving hair follicle stem cell function.

Scientists successfully made a human growth factor in a plant, which could help with hair growth and bone development.

Fibroblast Growth Factor-9 (FGF-9) can help improve heart function in diabetic mice after a heart attack by reducing inflammation and harmful changes to the heart's structure.

ASLNC168501 can help treat hair loss by restoring hair follicle stem cell function.

LGR5 mainly stays inside cells, moving to the trans-Golgi network, and this process is important for its role in cell signaling.

Compound 6 is a promising candidate for better wound healing.

Black women with CCCA are more likely to have uterine fibroids.

Microneedling with CGF significantly improves hair regrowth in androgenetic alopecia.

The most common sign of aging at the gene level is more Ectodysplasin A2 Receptor (EDA2R) being made.

TGF-β1 and 2 in hair follicles may be linked to hair loss in AGA.

The HGCA tool helps identify genes that work together by analyzing their co-expression patterns.

SFRP2 and PTGDS may be key factors in female hair loss.

Non-coding RNA boosts retinoic acid production and signaling, aiding regeneration.

TLR2 is important for hair growth and can be targeted to treat hair loss.

The E2 protein affects gene activity in hair follicles of mice.

A genetic change in the FGF5 gene affects hair growth in cashmere goats.

Human hair follicles have a unique way of using energy and might use the Cori cycle; blocking CCR5 could help treat hair loss.

Blocking glucocorticoid receptors improves glucose metabolism in a PCOS mouse model.

Oral contraceptive use may increase the risk of frontal fibrosing alopecia in women with a specific CYP1B1 gene variant.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

The Fas/FasL pathway may play a role in alopecia areata.

G-1 promotes hair growth in female mice by activating specific signaling pathways.

Inhibiting SFRP1 may help treat hair loss.